Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kolar

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of the American College of Nutrition|April 16, 1999
Effects of resistance vs. aerobic training combined with an 800 calorie liquid diet on lean body mass and resting metabolic rateR W Bryner, I H Ullrich, J Sauers, et al.
Musculoskeletal Surgery|January 20, 2021
11% complications rate after Latarjet procedure at up to 14 years follow-upB Marjanovic, B Poberaj, M Kolar, et al.
The New Microbiologica|May 22, 2002
The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic useM Kolar, I Vagnerova, T Latal, et al.
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases CentreM Kolar, D Duricova, M Bortlik, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech RepublicM Kolar, R Pantucek, I Vagnerova, et al.
Toxicology and Applied Pharmacology|December 3, 1999
Enhanced pulmonary epithelial replication and axial airway mucosubstance changes in F344 rats exposed short-term to mainstream cigarette smokeT H March, L M Kolar, E B Barr, et al.
Journal of Crohn'S & Colitis|January 7, 2020
Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical CentreMartin Lukas, K Malickova, M Kolar, et al.
Southern Medical Journal|March 11, 1999
Appalachian perspective on modifiable risk factors in coronary artery disease: how well are we doing?A K Halperin, D M Elnicki, H C Palmer, et al.
Journal of General Internal Medicine|February 15, 2000
Patient preferences for care by general internists and specialists in the ambulatory settingC L Lewis, G C Wickstrom, M M Kolar, et al.
Annals of the Royal College of Surgeons of England|March 1, 2021
Prophylactic antibiotic use in acellular dermal matrix-assisted implant-based breast reconstructionFak Mazari, G M Wattoo, N H Kazzazi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of the American College of Nutrition|April 16, 1999
Effects of resistance vs. aerobic training combined with an 800 calorie liquid diet on lean body mass and resting metabolic rateR W Bryner, I H Ullrich, J Sauers, et al.
Musculoskeletal Surgery|January 20, 2021
11% complications rate after Latarjet procedure at up to 14 years follow-upB Marjanovic, B Poberaj, M Kolar, et al.
The New Microbiologica|May 22, 2002
The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic useM Kolar, I Vagnerova, T Latal, et al.
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases CentreM Kolar, D Duricova, M Bortlik, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech RepublicM Kolar, R Pantucek, I Vagnerova, et al.
Toxicology and Applied Pharmacology|December 3, 1999
Enhanced pulmonary epithelial replication and axial airway mucosubstance changes in F344 rats exposed short-term to mainstream cigarette smokeT H March, L M Kolar, E B Barr, et al.
Journal of Crohn'S & Colitis|January 7, 2020
Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical CentreMartin Lukas, K Malickova, M Kolar, et al.
Southern Medical Journal|March 11, 1999
Appalachian perspective on modifiable risk factors in coronary artery disease: how well are we doing?A K Halperin, D M Elnicki, H C Palmer, et al.
Journal of General Internal Medicine|February 15, 2000
Patient preferences for care by general internists and specialists in the ambulatory settingC L Lewis, G C Wickstrom, M M Kolar, et al.
Annals of the Royal College of Surgeons of England|March 1, 2021
Prophylactic antibiotic use in acellular dermal matrix-assisted implant-based breast reconstructionFak Mazari, G M Wattoo, N H Kazzazi, et al.
Pageof 4